Author:
Macarron Ricardo,Banks Martyn N.,Bojanic Dejan,Burns David J.,Cirovic Dragan A.,Garyantes Tina,Green Darren V. S.,Hertzberg Robert P.,Janzen William P.,Paslay Jeff W.,Schopfer Ulrich,Sittampalam G. Sitta
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference66 articles.
1. LaMattina, J. L. (ed.) in Drug Truths: Dispelling the Myths About Pharma R&D 114–115 (John Wiley and Sons, Inc., Hoboken, New Jersey, 2009).
2. Graul, A. I., Revel, L., Tell, M., Rosa, E. & Cruces, E. Overcoming the obstacles in the pharma/biotech industry: 2009 update. Drug News Perspect. 23, 48–63 (2010).
3. Lahana, R. Who wants to be irrational? Drug Discov. Today 8, 655–656 (2003).
4. Landers, P. Human Element: drug industry's big push into technology falls short — testing machines were built to streamline research — but may be stifling it — officials see payoff after 2010. The Wall Street Journal 1 (24 Feb 2004).
5. Ashburn, T. T. & Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nature Rev. Drug Discov. 3, 673–683 (2004).
Cited by
964 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献